CBP Histone Acetyltransferase Activity Regulates Embryonic Neural Differentiation in the Normal and Rubinstein-Taybi Syndrome Brain
Overview
Reproductive Medicine
Authors
Affiliations
Increasing evidence indicates that epigenetic changes regulate cell genesis. Here, we ask about neural precursors, focusing on CREB binding protein (CBP), a histone acetyltransferase that, when haploinsufficient, causes Rubinstein-Taybi syndrome (RTS), a genetic disorder with cognitive dysfunction. We show that neonatal cbp(+/-) mice are behaviorally impaired, displaying perturbed vocalization behavior. cbp haploinsufficiency or genetic knockdown with siRNAs inhibited differentiation of embryonic cortical precursors into all three neural lineages, coincident with decreased CBP binding and histone acetylation at promoters of neuronal and glial genes. Inhibition of histone deacetylation rescued these deficits. Moreover, CBP phosphorylation by atypical protein kinase C zeta was necessary for histone acetylation at neural gene promoters and appropriate differentiation. These data support a model in which environmental cues regulate CBP activity and histone acetylation to control neural precursor competency to differentiate, and indicate that cbp haploinsufficiency disrupts this mechanism, thereby likely causing cognitive dysfunction in RTS.
Phillips M, Cook E, Marunde M, Tonelli M, Khan L, Henrickson A bioRxiv. 2024; .
PMID: 39713312 PMC: 11661176. DOI: 10.1101/2024.12.09.627393.
Loan A, Awaja N, Lui M, Syal C, Sun Y, Sarma S Theranostics. 2024; 14(16):6110-6137.
PMID: 39431007 PMC: 11488099. DOI: 10.7150/thno.97165.
Making Ramón y Cajal proud: Development of cell identity and diversity in the cerebral cortex.
Di Bella D, Dominguez-Iturza N, Brown J, Arlotta P Neuron. 2024; 112(13):2091-2111.
PMID: 38754415 PMC: 11771131. DOI: 10.1016/j.neuron.2024.04.021.
Bergamasco M, Vanyai H, Garnham A, Geoghegan N, Vogel A, Eccles S J Clin Invest. 2024; 134(7).
PMID: 38557491 PMC: 10977983. DOI: 10.1172/JCI167672.
Post-translational protein lactylation modification in health and diseases: a double-edged sword.
Gong H, Zhong H, Cheng L, Li L, Zhang D J Transl Med. 2024; 22(1):41.
PMID: 38200523 PMC: 10777551. DOI: 10.1186/s12967-023-04842-9.